Lantheus Holdings Inc

Healthcare · Drug Manufacturers - Specialty & Generic

100.00$ +0.3% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

Lantheus Holdings Inc (LNTH) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 2,415 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet LNTH
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	255	256	250	268	281	384	393	402	425	440	444	390	402	406	404	880	880	870	843	858	848	864	933	1,014	1,096	1,321	1,349	1,338	1,522	1,651	1,831	1,940	2,050	1,980	2,055	2,116	2,276	2,227	2,347	2,415
Current Assets	110	111	107	126	137	148	159	167	191	195	195	140	154	173	180	181	185	184	168	186	202	236	325	404	502	678	773	752	948	1,086	1,149	1,231	1,296	1,327	1,424	1,202	925	900	942	1,027
Cash	53	51	41	57	68	76	74	86	105	113	112	57	78	93	96	90	88	80	69	92	91	99	105	171	257	416	471	414	614	714	718	757	866	913	939	696	382	359	499	593
Cash & Short-Term Investments	53	51	41	57	68	76	74	86	105	113	112	57	78	93	96	90	88	80	69	92	91	99	105	171	257	416	471	414	614	714	718	757	866	913	939	696	382	359	499	593
Receivables	35	37	40	43	42	40	48	44	47	44	45	46	41	44	45	47	49	54	59	55	64	89	172	187	197	213	242	256	259	284	337	372	329	321	349	337	383	359	356	353
Inventory	16	18	20	21	23	26	32	31	35	33	32	32	31	29	31	35	38	36	30	32	34	35	34	34	35	35	42	52	56	64	70	71	71	68	69	62	62	65	61	58
Property, Plant & Equipment	85	94	92	92	95	93	94	97	99	108	112	113	114	117	109	123	122	120	118	118	116	117	126	119	129	141	–	130	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	16	16	16	16	16	16	16	16	16	16	16	16	16	16	16	58	58	59	61	61	61	61	61	61	61	61	61	61	61	61	61	61	61	61	61	177	240	240	239	239
Intangible Assets	24	15	14	13	13	12	11	10	9.7	9.1	8.7	8.2	7.8	7.3	6.9	390	385	376	371	365	357	349	340	332	324	315	220	221	163	152	142	172	174	162	154	360	739	723	706	689
Total Liabilities	376	362	351	355	359	361	359	357	369	369	361	298	301	291	286	364	366	356	315	350	348	399	417	446	458	874	904	785	823	835	886	913	870	892	891	949	1,157	1,138	1,134	1,103
Current Liabilities	39	44	39	43	46	47	45	43	55	53	43	53	60	66	62	76	82	81	65	74	77	90	178	219	236	248	276	154	177	187	237	263	784	241	248	280	347	333	333	336
Short-Term Debt	3.7	3.7	2.8	2.8	2.8	2.8	2.8	2.8	2.8	2.8	2.9	10	10	10	10	17	18	21	10	10	10	12	13	14	15	0.4	0.4	0.4	0.7	0.8	0.7	0.9	565	1.0	0.7	0.8	0.9	4.5	0.8	0.7
Accounts Payable	14	19	18	18	19	17	21	15	20	18	15	17	16	19	19	16	24	16	19	21	21	21	22	21	30	21	31	39	37	41	38	50	45	35	45	41	66	43	46	48
Long-Term Debt	295	274	266	266	266	265	265	265	264	264	263	189	186	184	181	210	205	198	171	169	167	163	159	156	152	558	559	559	561	562	562	563	0.6	565	566	567	568	569	570	570
Shareholders' Equity	-121	-107	-101	-87	-78	23	34	45	56	71	83	92	101	115	118	516	514	514	528	508	499	464	516	567	638	447	446	553	699	816	946	1,027	1,180	1,088	1,164	1,167	1,119	1,090	1,212	1,312
Retained Earnings	-337	-332	-328	-315	-306	-209	-200	-191	-181	-168	-158	-152	-147	-136	-133	-140	-147	-150	-141	-168	-181	-221	-178	-135	-74	-193	-196	-102	30	134	265	327	458	446	519	598	625	680	798	873
Shares Outstanding	32	38	39	39	39	39	39	39	39	39	40	40	40	40	40	43	67	67	68	68	68	68	70	71	71	69	68	71	70	70	70	71	73	69	71	70	68	66	66	68

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings